Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US2307701092
Ticker CPIX
Company CUMBERLAND PHARMACEUTICALS
Currency $
Price
Aware Investor Index (AII) 0.0000
Recommendation STRONG SELL
P/E 411.19
ROE 0.40 %
Capitalization 90,873,783 $
Dividend Yield 0.00 %
P/S 2.23
AII Position 731
P/E Position 726
ROE Position 727
Capitalization Position 732
Dividend Yield Position 594
Sales 40,742,000 $
10-Year Average Earnings 221,000 $
Shares Outstanding 15,614,052
Equity 55,571,000 $
Dividend per Share 0 $
Industry Pharmaceutical
Country United States
CUMBERLAND PHARMACEUTICALS Investor Relations Web Site http://investor.shareholder.com/cpix/index.cfm







Sales:

YEAR MONTH AMOUNT
2018 12 40,742,000.00 $
2017 12 41,150,000.00 $
2016 12 33,026,000.00 $
2015 12 33,519,000.00 $
2014 12 36,901,000.00 $
2013 12 32,027,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 -6,963,000.00 $
2017 12 -7,979,000.00 $
2016 12 -945,000.00 $
2015 12 731,000.00 $
2014 12 2,423,000.00 $
2013 12 -2,105,000.00 $
2012 12 5,842,000.00 $
2011 12 5,658,000.00 $
2010 12 2,457,000.00 $
2009 12 3,091,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 55,571,000.00 $
2017 12 63,922,000.00 $
2016 12 73,121,000.00 $
2015 12 76,820,000.00 $
2014 12 80,752,791.00 $
2013 12 79,292,000.00 $
2012 12 85,566,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 15,614,052
2017 12 15,911,577
2016 12 16,236,525
2015 12 17,094,754
2014 12 17,899,632
2013 12 18,332,997
2012 12 19,787,537

 












Bloomberg News for CUMBERLAND PHARMACEUTICALS:



Google News for CUMBERLAND PHARMACEUTICALS:

CryptoCoinsTribune - 13 hours ago
Cumberland Pharmaceuticals Inc. (CPIX) At $5.89 Forms Bottom ...
Cumberland Pharmaceuticals Inc. (CPIX) formed multiple bottom with $5.71 target or 3.00% below today's $5.89 share price. Cumberland ...
Invest Tribune
$-0.18 EPS Expected for Cumberland Pharmaceuticals Inc. (CPIX ...
Analysts expect Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) to report $-0.18 EPS on May, 14.They anticipate $0.07 EPS change or ...
The qxcSN
Cumberland Pharmaceuticals Inc Sentiment Worsening on Low ...
Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) institutional sentiment decreased to 0.25 in 2018 Q4. Its down -1.92, from 2.17 in 2018Q3.
CryptoCoinsTribune - 3 hours ago
Cumberland Pharmaceuticals (NASDAQ:CPIX) Shareholders Have ...
Unfortunately for shareholders, while the Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) share price is up 33% in the last five years, that's ...
Invest Tribune - 8 hours ago
Cumberland Pharmaceuticals Announces Strategic Review
NASHVILLE, Tenn., March 29, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company ...
Simply Wall St - 27 Mar 2019
Cumberland Pharmaceuticals' (CPIX) CEO AJ Kazimi on Q4 2018 ...
Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) Q4 2018 Earnings Conference Call February 26, 2019 4:30 PM ET. Company Participants.
PRNewswire (press release) - 29 Mar 2019
Cumberland Pharmaceuticals: One Step Forward Isn't Enough
For years, the problem with small-cap specialty pharmaceutical company Cumberland Pharmaceuticals (CPIX) has been a lack of progress.
Seeking Alpha - 26 Feb 2019
Cumberland Pharmaceuticals beats by $0.35, beats on revenue
Cumberland Pharmaceuticals (NASDAQ:CPIX): Q4 Non-GAAP EPS of $0.10 beats by $0.35; GAAP EPS of -$0.14 beats by $0.11. Revenue of ...
Seeking Alpha - 28 Dec 2018
Theravance Biopharma (TBPH) to Sell VIBATIV to Cumberland ...
Theravance Biopharma (TBPH) to Sell VIBATIV to Cumberland Pharmaceuticals (CPIX) ... Under the terms of the agreement, Cumberland will pay Theravance ... "This transaction with Cumberland Pharmaceuticals allows ...
Seeking Alpha - 26 Feb 2019
How Financially Strong Is Cumberland Pharmaceuticals Inc ...
While small-cap stocks, such as Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) with its market cap of US$86.2m, are popular for their ...


Back